Global and China Industrial Enzyme Industry Report, 2014-2017
  • June 2015
  • Hard Copy
  • USD $2,150
  • Pages:85
  • Single User License
    (PDF Unprintable)       
  • USD $2,000
  • Code: ZLC020
  • Enterprise-wide License
    (PDF Printable & Editable)       
  • USD $3,100
  • Hard Copy + Single User License
  • USD $2,350

In recent years, the global industrial enzyme preparation market size increased year by year, registering a CAGR of 5%, approximating USD4.2178 billion in 2014. At present, the global industrial enzyme market is basically an oligopoly. In 2014, Novozymes, an industrial enzyme giant, accounted for a 44% market share while that for Dupont and DSM was 20% and 6%, respectively.

Regionally, Europe and North America have the largest demand for industrial enzyme, occupying nearly 80% in sharp contrast to some 9.4% in China.

Stimulated by the growing demand for enzyme preparations and favorable policies, China's industrial enzyme preparation output reached 1.1657 million tons in 2014. For years to come, industrial enzyme output will keep 10% growth rate, to 1.5487 million tons by 2017.

By introducing foreign advanced equipment, excellent strains, and new-type enzyme preparations, China has scored rapid development of enzyme preparation industry, especially the Chinese enzyme preparation enterprises. Currently, the enterprises with strong competitive power in China include VTR Bio-Tech, Youtell Biochemical, Smistyle, SunHY, etc.

As an enzyme preparation leader in China, VTR Bio-Tech has two subsidiaries: VTR Bio-Tech (Inner Mongolia) and Hunan Hong Ying Xiang Biochemistry (acquiring a 75% stake in 2014), with an annual capacity of 186,000 tons. In 2014, the company recorded revenue of RMB359.82 million and net income of RMB55.13 million (excluding that of Hunan Hong Ying Xiang). At present, VTR Bio-Tech (Inner Mongolia)’s 20,000 tons/a enzyme preparation project and Hunan Hong Ying Xiang’s 140,000 tons/a enzyme preparation project have been jumpstarted.

Youtell boasts advanced R&D center in the United States and two large fermentation production bases in Hunan and Shandong, with the annual production scale approaching 80,000 tons but lower capacity utilization. In 2014, the company posted RMB153.9 million in revenue and RMB10.74 million in net income.

Global and China Enzyme Preparation Industry, 2014-2017 is all about the following:
20120114.gifDevelopment of global industrial enzyme industry, including market size, competition pattern, and demand structure;
20120114.gifDevelopment of China’s industrial enzyme industry, including development history, policy environment, development status, import and export, and competition pattern;
20120114.gifDevelopment of downstream sectors of China’s enzyme preparation industry, including food, feedstuff, brewing, detergent, papermaking, and textile industries;
20120114.gifFour global and nine major Chinese industrial enzyme manufacturers, including their profile, operation, and their industrial enzyme business.

酶制剂 英文_副本改.png

1 Overview of Industrial Enzyme 

2 Development of Global Industrial Enzyme Industry 
2.1 Market Size 
2.2 Competition Pattern
2.3 Demand Structure

3 Development of China Industrial Enzyme Industry
3.1 Development History
3.2 Policy Environment
3.3 Development Status
3.4 Import and Export
3.4.1 Import
3.4.2 Export
3.5 Competition Pattern 

4 Development of Downstream Sectors of China Enzyme Preparation Industry
4.1 Food Industry
4.1.1 Starch Processing
4.1.2 Bakery Product
4.1.3 Condiments
4.2 Feedstuff Industry
4.3 Brewing Industry
4.3.1 Spirit
4.3.2 Beer
4.3.3 Wine
4.3.4 Yellow Wine
4.4 Detergent Industry
4.5 Papermaking Industry
4.6 Textile Industry

5 Major Foreign Companies
5.1 Novozymes 
5.1.1 Profile
5.1.2 Operation
5.1.3 Revenue Structure
5.1.4 Gross Margin
5.1.5 R&D and Investment
5.1.6 Development in China
5.2 ABF
5.2.1 Profile
5.2.2 Operation
5.2.3 Revenue Structure
5.2.4 Gross Margin
5.2.5 R&D
5.2.6 Enzyme Business
5.2.7 Development in China
5.3 DSM
5.3.1 Profile
5.3.2 Operation
5.3.3 Revenue Structure
5.3.4 Gross Margin
5.3.5 R&D and Investment
5.3.6 Enzyme Business
5.3.7 Development in China
5.4 Danisco (Genencor)
5.4.1 Profile
5.4.2 Development in China

6 Major Domestic Companies
6.1 VTR Bio-Tech
6.1.1 Profile
6.1.2 Operation
6.1.3 Revenue Structure
6.1.4 Gross Margin
6.1.5 R&D and Investment
6.1.6 Production and Sales
6.1.7 Major Clients
6.1.8 Forecast and Outlook
6.2 Youtell Biochemical
6.2.1 Profile
6.2.2 Operation
6.2.3 Development History
6.3 Beijing Challenge Bio-technology
6.3.1 Profile
6.3.2 Operation
6.4 Smistyle
6.4.1 Profile
6.4.2 Operation
6.5 Longda Bio-products 
6.5.1 Profile
6.5.2 Operation
6.6 Vland Biotech
6.6.1 Profile
6.6.2 Operation
6.7 SunHY
6.7.1 Profile
6.7.2 Operation
6.7.3 R&D
6.8 Sunson 
6.8.1 Profile
6.8.2 Operation
6.9 Senzymes Biotechnology
6.9.1 Profile
6.9.2 Operation

7 Forecast and Outlook 
7.1 Global Industrial Enzyme Market
7.2 China Industrial Enzyme Market
Classification of Enzyme (by Nature of Catalytic Reaction) 
Biological Enzyme Preparation Production Technology and Core Technology
Global Industrial Enzyme Preparation Market Size and YoY Growth Rate, 2007-2014
Global Industrial Enzyme Market Share, 2014 
Global Industrial Enzyme Demand Structure (by Region), 2014
Development History of China’s Industrial Enzyme Preparation Industry
Policies on China’s Industrial Enzyme Preparation Industry
China’s Industrial Enzyme Preparation Output and YoY Growth, 2006-2014
China’s Industrial Enzyme Preparation Output (by Product), 2014
China’s Industrial Enzyme Preparation Output Percentage (by Product), 2014
China’s Industrial Enzyme Preparation Import Volume and YoY Growth Rate, 2009-2014
China’s Industrial Enzyme Preparation Import Value and YoY Growth Rate, 2009-2014  
Top 10 Countries and Regions by Import Volume of China’s Industrial Enzyme Preparations, 2014 
China's Industrial Enzyme Preparation Export Volume and YoY Growth Rate, 2009-2014
China's Industrial Enzyme Preparation Export Value and YoY Growth Rate, 2009-2014
Top 10 Countries and Regions by Export Volume of China’s Industrial Enzyme Preparations, 2014
Average Price of China's Industrial Enzyme Preparation Import and Export, 2009-2014
Capacity of Major Enzyme Preparation Manufacturers in China, 2014  
China's Starch Output, 2009-2014 
China’s Starch Output Percentage by Product, 2014
China’s Starch Import and Export by Product, 2013-2014 
Revenue and Total Profit of Chinese Bakery Enterprises, 2008-2014
Revenue and Total Profit of Chinese Condiment Enterprises, 2008-2014  
China's Feedstuff Output and YoY Growth Rate, 2009-2014 
China’s Mixed Feed Output and YoY Growth Rate, 2009-2014 
China’s Premix Feedstuff Output and YoY Growth Rate, 2009-2014 
China's Additive Premix Feedstuff Output and YoY Growth Rate, 2009-2014
China’s Feedstuff additive Output Percentage by Category, 2014  
China's Spirit Output and YoY Growth Rate, 2009-2014
Revenue and Total Profit of Chinese Spirit Companies, 2009-2014 
Application of Various Enzyme Products in Beer Brewing
China's Beer Output and YoY Growth Rate, 2009-2014  
Revenue and Total Profit of Chinese Beer Enterprises, 2009-2014 
China's Wine Output and YoY Growth, 2009-2014
Revenue and Total Profit of Chinese Wine Enterprises, 2009-2014
Revenue and Total Profit of Chinese Yellow Wine Enterprises, 2009-2014
China's Synthetic Detergent Output and YoY Growth, 2009-2014 
China's Detergent Export Volume and YoY Growth, 2009-2014
China's Pulp Output and YoY Growth, 2009-2014  
China's Pulp Import Volume and YoY Growth, 2009-2014  
China's Fabric Output and YoY Growth, 2009-2014  
Novozymes’ Revenue and Net Income, 2010-2014  
Novozymes’ Revenue Breakdown by Sector, 2012-2014  
Novozymes’ Revenue Structure by Sector, 2012-2014  
Novozymes’ Revenue Breakdown by Region, 2013-2014  
Novozymes’ Revenue Structure by Region, 2013-2014  
Novozymes’ Gross Margin, 2010-2014  
Novozymes’ R&D Costs and % of Total Revenue, 2012-2014   
Novozymes’ M&A Progress and Engineering Construction, 1967-2013  
Novozymes’ Milestones in China and Big Events
Registered Capital and Shareholding Ratio of Novozymes’ Subsidiaries in China 
ABF’s Revenue and Net Income, FY2012-FY2014  
ABF’s Revenue Breakdown by Segment, FY2012-FY2014  
ABF’s Revenue Structure by Segment, 2012-2014  
ABF’s Gross Margin, 2012-2014  
ABF’s R&D Costs and % of Total Revenue, 2012-2014  
ABF’s Ingredient Revenue and % of Total Revenue, FY2012-FY2014  
DSM’s Revenue and Net Income, 2010-2014  
DSM’s Revenue Breakdown by Segment, 2013-2014  
DSM’s Revenue Structure by Segment, 2013-2014  
DSM’s Revenue Breakdown by Region, 2010-2014  
DSM’s Revenue Structure by Region, 2010-2014  
DSM’s Gross Margin’s 2010-2014  
DSM’s R&D Costs and % of Total Revenue, 2010-2014  
DSM’s Nutrition Revenue, YoY Growth, and % of Total Revenue, 2010-2014
DSM’s Development in China
DSM’s Major Arms in China
DSM’s Revenue, YoY Growth, and % of Total Revenue in China, 2010-2014  
Danisco’s Operating Companies in China 
VTR Bio-Tech’s Revenue and Net Income, 2010-2014  
VTR Bio-Tech’s Revenue Breakdown by Product, 2010-2014  
VTR Bio-Tech’s Revenue Structure by Product, 2010-2014  
VTR Bio-Tech’s Revenue Breakdown by Region, 2010-2014   
VTR Bio-Tech’s Revenue Structure by Region, 2010-2014  
VTR Bio-Tech’s Gross Margin of VTR Bio-Tech, 2010-2014  
VTR Bio-Tech’s Gross Margin by Product, 2010-2014  
VTR Bio-Tech’s Gross Margin by Region, 2010-2014  
VTR Bio-Tech’s R&D Costs and % of Total Revenue, 2010-2014  
Major Research Projects of VTR Bio-Tech as of the End of 2014
VTR Bio-Tech’s Production and Sales by Product, 2013-2014  
VTR Bio-Tech’s Revenue from Top 5 Clients and % of Total Revenue, 2010-2014  
VTR Bio-Tech’s Revenue and Net Income, 2013-2017E
Youtell's Revenue and Net Income, 2010-2014 
Youtell's Total Assets, Net Assets, and Asset-liability Ratio, 2010-2014  
Youtell's Development History
SunHY's Subsidiaries
SunHY's Main Product Lines 
Global Industrial Enzyme Preparation Market Size and YoY Growth, 2013-2017E
China's Industrial Enzyme Preparation Output and YoY Growth, 2013-2017E

China Human Vaccine Industry Report, 2019-2025

China has been the world’s biggest producer and consumer of human vaccines over four decades of planned vaccination, a program that has reduced incidence of multiple vaccine-targeted infectious diseas...

China Independent Clinical Laboratory Industry Report, 2019-2025

China's independent clinical laboratory industry is still in its infancy. In 2018, it only saw the penetration rate of about 5%, far below 40% or more in Europe, the United States and Japan. The main ...

Global and China Monoclonal Antibody Industry Report, 2019-2025

Global monoclonal antibody market can be presented as follows: 1. Monoclonal antibody drug market booms and is highly concentrated with the approvals for such drugs.Monoclonal antibody drugs have bee...

China Contract Research Organization (CRO) Industry Report, 2019-2025

The steadily growing global pharmaceutical industry where more and more new drugs have been approved, and the soaring spending on drug research and development in recent years, are a boon for global c...

China Blood Product Industry Report, 2019-2025

With the adjustment of the national medical insurance catalogue, the clinical application and reimbursement rate of almost all blood products have been greatly improved, and the market for blood produ...

China Human Vaccine Industry Report, 2018-2022

As the world’s largest producer of human vaccines, China has established a full-life-cycleregulatory system covering vaccine R&D, production, distribution, and vaccination. The lot release volum...

China Contract Research Organization(CRO) Industry Report, 2017-2021

Under the pressure from higher R&D costs, longer R&D cycle and lower R&D success rate in pharmaceutical industry worldwide, over 50 percent of pharmaceutical enterprises have had the devel...

China Vacuum Blood Collection Device Industry Report, 2017-2021

China’s vacuum blood collection device industry now flourishes after start-up and growth stages. Along with steady improvement in economic environment, rising per-capita disposable income, greater awa...

China Independent Clinical Laboratory Industry Report, 2017-2021

China's independent clinical laboratory industry started late, and is still in its infancy. In 2016, it only saw the penetration rate of about 4%, far below 40% or more in Europe, the United States an...

China Human Vaccine Industry Report, 2017-2021

The human vaccine industry presented the following main characteristics in 2016 in China: 1. Lot release volume of human vaccines declined.Affected by the illegal vaccine case in Mar 2016 in Shandong...

China Independent Clinical Laboratory Industry Report, 2016-2020

Owing to a large population base, uneven distribution of medical resources among regions, aging population, and continuous advance of health care reform, the Chinese independent clinical laboratory ma...

China Human Vaccine Industry Report, 2016-2020

Amid the unsafe domestic vaccine events, China’s human vaccine lot release volume in 2015 fell by 17.9% year on year to only 650 million doses,touching a 5-year low. Moreover, with the improvements in...

China Animal Vaccine Industry Report, 2016-2020

Animal vaccine is a kind of biological agent that enables inoculated animals to produce active immunity for disease prevention. In recent years, European and American animal vaccine markets have seen ...

China Blood Product Industry Report, 2016-2019

Recombinant blood products have developed for many years in foreign countries, but China’s blood products are still proteins extracted from human blood. Thus, reserves and control of plasma resources ...

China Contract Research Organization (CRO) Industry Report, 2015-2018

In recent years, China's contract research organization (CRO) industry has developed rapidly, with the market size rising from RMB8.5 billion in 2007 to RMB42.6 billion in 2014, registering a CAGR of ...

Global and China Industrial Enzyme Industry Report, 2014-2017

In recent years, the global industrial enzyme preparation market size increased year by year, registering a CAGR of 5%, approximating USD4.2178 billion in 2014. At present, the global industrial enzym...

China Blood Product Industry Report, 2015-2018

Recombinant blood products have developed for many years in foreign countries, but China’s blood products are still proteins extracted from human blood. Thus, reserves and control of plasma resources ...

China Human Vaccine Industry Report, 2015-2018

A vaccine is a preventive biological product for human use that prevents and controls the occurrence and prevalence of infectious diseases, so the demand for such products is relatively rigid. Due to ...

2005- All Rights Reserved 京ICP备05069564号-1 京公网安备1101054484号